Trial intelligence / Profile preview

Estrogen Replacement Therapy for Adolescent Anorexia Nervosa

2024-519908-27-01Phase 2Completed

Sponsor
University Hospital of North Norway
Start
Jan 2025
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of estradiol in anorexia nervosa (AN), sponsored by University Hospital of North Norway. Primary endpoints: Anxiety levels by STAI-C and Eating disorder symptoms by EDE-Q. Started Jan 2025; status: completed.

02

Drugs

estradiol
03

Conditions

anorexia nervosa (AN)

Beyond the preview

Go deeper on 2024-519908-27-01.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-519908-27-01.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call